Sight Sciences (SGHT) COO sells shares to cover RSU tax, retains 664,709 stake
Rhea-AI Filing Summary
Sight Sciences, Inc. Chief Operating Officer Alison Bauerlein reported an open-market sale of 24,184 shares of common stock at a weighted average price of $5.36 per share. According to the disclosure, the sale was made to cover her tax liability arising from the vesting of restricted stock units. After this transaction, she holds a total of 664,709 shares, including 192,669 shares of common stock and 472,040 shares subject to unvested restricted stock units that may be acquired upon future vesting and settlement.
Positive
- None.
Negative
- None.
Insights
COO’s sale is mainly tax-related and small versus total equity stake.
The transaction shows COO Alison Bauerlein sold 24,184 shares of Sight Sciences at a weighted average of $5.36 per share. The company states the sale was made to cover tax liabilities from recently vested restricted stock units, which is a common administrative event.
After the sale she still holds 664,709 shares, combining 192,669 common shares and 472,040 shares tied to unvested RSUs. This indicates the sale is a small fraction of her overall equity exposure. The filing also notes the shares were sold in multiple trades between $5.19 and $5.46 per share, but does not reference any trading plan.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 24,184 | $5.36 | $130K |
Footnotes (1)
- Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 192,669 shares of Common Stock, and (ii) 472,040 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.